104 related articles for article (PubMed ID: 6433638)
1. Differences in capping behavior between immunological phenotypes in childhood acute lymphoblastic leukemia. A study with ConA and an anti-HLA-ABC backbone.
Hogeman PH; Veerman AJ; Huismans DR; Bezemer PD
Acta Haematol; 1984; 72(1):7-13. PubMed ID: 6433638
[TBL] [Abstract][Full Text] [Related]
2. Significance of number of HLA determinants in HLA capping in childhood acute lymphoblastic leukemia.
Hogeman PH; Veerman AJ; Philippus E; Huismans DR; van Zantwijk CH; Bezemer PD
Acta Haematol; 1985; 73(4):196-200. PubMed ID: 2414955
[TBL] [Abstract][Full Text] [Related]
3. Capping of leukemic cells with monoclonal anti-HLA-A,B,C related to prognosis in childhood acute lymphoblastic leukemia.
Hogeman PH; Veerman AJ; Huismans DR; van Zantwijk CH; Bezemer PD
Acta Haematol; 1986; 76(2-3):119-23. PubMed ID: 3101348
[TBL] [Abstract][Full Text] [Related]
4. HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia.
von Fliedner VE; Sultan Khan Z; Jeannet M
Acta Haematol; 1981; 65(2):73-8. PubMed ID: 6785965
[TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
6. Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes.
Stark RS; Liebes LF; Shelanski ML; Silber R
Blood; 1984 Feb; 63(2):415-20. PubMed ID: 6537890
[TBL] [Abstract][Full Text] [Related]
7. [A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens].
Ruiz-Cabello F; González M; López MA; Cabrera A; San Miguel J; Garrido F
Sangre (Barc); 1985; 30(2):190-6. PubMed ID: 3859940
[No Abstract] [Full Text] [Related]
8. Handmirror cells in childhood acute lymphoblastic leukemia related to immunological phenotype.
Hogeman PH; Veerman AJ; de Waal FC; Bezemer PD; Huismans DR; van Zantwijk CH
Am J Pediatr Hematol Oncol; 1985; 7(3):217-20. PubMed ID: 3865553
[TBL] [Abstract][Full Text] [Related]
9. [T-cell chronic lymphocytic leukemia].
Semenzato G; Pandolfi F
Haematologica; 1983; 68(2):245-86. PubMed ID: 6407919
[No Abstract] [Full Text] [Related]
10. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
13. The anomalous capping behavior of chronic lymphocytic leukemia lymphocytes: studies with an antilymphocyte antiserum.
Liebes L; Quagliata F; Silber R
Clin Immunol Immunopathol; 1978 Jun; 10(2):222-32. PubMed ID: 352593
[No Abstract] [Full Text] [Related]
14. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
15. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
16. [HLA phenotypes in patients surviving a long time after immunotherapy with BCG for acute childhood lymphoblastic leukemia. Arguments in favor of the existance of a gene for immune response in human leukemia].
Tursz T; Hors J; Lipinski M; Amiel JL
C R Acad Hebd Seances Acad Sci D; 1977 Dec; 285(16):1585-7. PubMed ID: 417839
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-DR antigens and cell proliferation in acute lymphoblastic leukemia of children.
Hirt A; Baumgartner C; Imbach P; Luethy A; Wagner HP
Acta Haematol; 1984; 72(1):1-6. PubMed ID: 6433625
[TBL] [Abstract][Full Text] [Related]
18. A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies.
Link M; Warnke R; Finlay J; Amylon M; Miller R; Dilley J; Levy R
Blood; 1983 Oct; 62(4):722-8. PubMed ID: 6603882
[TBL] [Abstract][Full Text] [Related]
19. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses.
Thoene I; Kabisch H
Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949
[No Abstract] [Full Text] [Related]
20. Motility of leukaemic cells in acute leukaemia related to tumour mass, maturation and FAB classification.
van der Weide M; Imandt LM; Langenhuijsen MM
Acta Haematol; 1988; 80(1):34-9. PubMed ID: 3135690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
